Showing results (311-320 of 10,340) with videos related to

Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|September 23, 2020
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosisYannick Allanore, Peter Wung, Christina Soubrane, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, et al.
Annals of the Rheumatic Diseases|June 1, 1988
A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosusC G Mackworth-Young, J David, S H Morgan, et al.
Annals of the Rheumatic Diseases|September 29, 2020
Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound studyGeorgios Filippou, Anna Scanu, Antonella Adinolfi, et al.
Annals of the Rheumatic Diseases|October 8, 2020
Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvementKimberly Showalter, Robert Spiera, Cynthia Magro, et al.
Annals of the Rheumatic Diseases|March 13, 2020
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factorsHjalmar Wadström, Andreas Pettersson, Karin E Smedby, et al.
Annals of the Rheumatic Diseases|March 2, 2020
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of goutViola Klück, Rosanne C van Deuren, Giulio Cavalli, et al.
Annals of the Rheumatic Diseases|January 26, 2019
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosusShereen Oon, Molla Huq, Vera Golder, et al.
Annals of the Rheumatic Diseases|January 26, 2019
PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypesShuji Akizuki, Kazuyoshi Ishigaki, Yuta Kochi, et al.
Annals of the Rheumatic Diseases|November 30, 2019
Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosusMaria Grigoriou, Aggelos Banos, Anastasia Filia, et al.
Pageof 1,034